BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35822337)

  • 1. Attaining biochemical euthyroidism early after total thyroidectomy in Graves' disease may lower long-term morbidity risk.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
    BJS Open; 2022 Jul; 6(4):. PubMed ID: 35822337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
    Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
    Cochrane Database Syst Rev; 2015 Nov; (11):CD010576. PubMed ID: 26606533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism.
    Lin YS; Lin JD; Hsu CC; Yu MC
    J Surg Res; 2017 Dec; 220():112-118. PubMed ID: 29180171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal TSH Prior to Surgery in Children with Graves' Disease Predicts Abnormal TSH Following Thyroidectomy.
    Hazkani I; Stein E; Edwards E; Maddalozzo J; Johnston D; Samis J; Josefson J; Rastatter J
    Laryngoscope; 2023 Sep; 133(9):2402-2406. PubMed ID: 36370147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
    Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
    Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
    Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
    World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease. Prognostic factors.
    Moreno P; Gómez JM; Gómez N; Francos JM; Ramos E; Rafecas A; Jaurrieta E
    World J Surg; 2006 Nov; 30(11):1950-6. PubMed ID: 17006611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' Disease: Can It Be Cured?
    Wiersinga WM
    Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
    Palit TK; Miller CC; Miltenburg DM
    J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy.
    Ryödi E; Metso S; Huhtala H; Välimäki M; Auvinen A; Jaatinen P
    Thyroid; 2018 Sep; 28(9):1111-1120. PubMed ID: 29882483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
    Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Na+,K+ATPase activity in red blood cells in euthyroid women treated with levothyroxine after total thyroidectomy for Graves' disease.
    De Riva C; Vircici F
    Metabolism; 1998 Oct; 47(10):1194-8. PubMed ID: 9781620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIS mRNA expression level in resected thyroid tissue as a marker of postoperative hypothyroidism after subtotal thyroidectomy in patients with Graves' disease.
    Goto A; Uchino S; Noguchi S; Wakiya S; Watanabe Y; Murakami T; Matsuura B; Onji M
    Endocr J; 2008 Mar; 55(1):73-81. PubMed ID: 18187871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid function after subtotal thyroidectomy in patients with Graves' hyperthyroidism.
    Limonard EJ; Bisschop PH; Fliers E; Nieveen van Dijkum EJ
    ScientificWorldJournal; 2012; 2012():548796. PubMed ID: 22448136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
    Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
    Br J Surg; 2022 Mar; 109(4):381-389. PubMed ID: 35136950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
    Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.